Related Experiment Videos
[Thrombomodulin in diabetic retinopathy]
Nippon Ganka Gakkai Zasshi
|March 1, 1994
Summary
Plasma thrombomodulin levels increase with diabetic retinopathy severity. Monitoring this marker may help predict retinopathy progression and indicate vascular injury.
Area of Science:
- Biochemistry
- Vascular Biology
- Ophthalmology
Context:
- Thrombomodulin is an endothelial cell surface glycoprotein.
- Circulating thrombomodulin antigens, released from injured cells, are potential markers of vascular endothelial cell injury.
- Diabetic retinopathy involves progressive damage to retinal blood vessels.
Purpose:
- To investigate the relationship between plasma thrombomodulin levels and the severity of diabetic retinopathy.
- To assess plasma thrombomodulin as a potential biomarker for diabetic retinopathy progression.
Summary:
- Plasma thrombomodulin levels were significantly elevated in patients with more advanced stages of diabetic retinopathy compared to those with no or less severe retinopathy.
- Statistical analysis (Mann-Whitney U test) confirmed significant differences in plasma thrombomodulin levels between various stages of retinopathy, including proliferative stages.
- The findings suggest a correlation between ocular vascular injury in diabetic retinopathy and systemic vascular health, as indicated by plasma thrombomodulin.
Impact:
- Plasma thrombomodulin may serve as a novel, non-invasive biomarker for monitoring diabetic retinopathy progression.
- This research could lead to earlier detection and intervention strategies for patients at risk of severe vision loss due to diabetes.
- Understanding the link between plasma thrombomodulin and retinopathy severity may offer insights into the systemic vascular complications associated with diabetes.